Glenmark Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

1541.65

+0.85 (+0.06%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

1541.65

+0.85 (+0.06%)
16:02 Dec 20

Quality

19/100
Low Financial Strength

Valuation

12/100
Expensive Valuation

Technical

57/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM 2024
Net Sales	10943.93	12304.9	12990.11	11813.1	12247.64
Operating Expenses +	8859.56	9984.6	10711.74	10617.76	10761.82
Raw Material	3888.07	4396.42	4862.05	4608.99	4298.96
Increase Decrease in Cost	-189.25	-11.14	-325.09	-195.62	-91.01
Other Manufacturing Expense	44.99	74.42	0	0	0
Employee Cost	2343.71	2447.42	2780.96	2868.14	2951
Miscellaneous Expenses	4272.58	5312.8	5930.34	6238.59	3602.87
Operating Profit	2084.37	2320.3	2278.37	1195.34	1485.82
Other Income	50.22	166.67	316.79	839.99	889.48
Depreciation	443.55	486.72	611.27	581.91	536.49
Interest	353.11	298.1	349.58	515.97	370.96
Profit before tax and exceptio..	1337.93	1702.16	1634.3	937.45	1467.85
Exceptional Items	44.54	-260.91	-765.85	-900.96	-523.5
PBT	1382.48	1441.25	868.45	36.5	1991.35
Provision for Taxation	412.39	447.6	491.05	1867.34	1937.86
Net Profit	970.09	993.65	377.4	-1433.52	-850.37
NET Profit after MI	970.04	941.71	297.24	-1501.67	-875.18
EPS	34.38	33.37	10.53	-53.22	-31.02
Operating Profit Margin (%)	19.05	18.86	17.54	10.12	12.13
Net Profit Margin (%)	8.86	7.65	2.29	-12.71	-7.15

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	46.60	46.60	46.60	46.60	46.60
FII	23.00	21.00	21.40	23.70	24.80
MF	11.40	10.90	10.60	8.60	7.30
Public	17.10	18.40	18.60	18.70	18.20
Others	0.00	0.00	0.00	0.00	0.10
Others	1.90	3.10	2.80	2.40	3.00